Advertisement

Stocks That Hit 52-Week Lows On Monday

Benzinga Insights 5 years ago

NewsIntraday UpdateMarketsMoversTrading Ideas

  Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows.

 

Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows.

Interesting Highlights:

  • The largest company by market cap to set a new 52-week low was Ionis Pharmaceuticals (NASDAQ:IONS).
  • The smallest company by market cap to hit a new 52-week low was Millendo Therapeutics (NASDAQ:MLND).
  • Qualigen Therapeutics (NASDAQ:QLGN)'s stock dropped the most, trading down 14.23% to reach a new 52-week low.

During the first half-hour of trading on Monday, the following stocks set new 52-week lows:

  • Ionis Pharmaceuticals (NASDAQ:IONS) stock set a new 52-week low of $41.19 on Monday, moving down 2.14%.
  • Sarepta Therapeutics (NASDAQ:SRPT) stock set a new 52-week low of $68.51 on Monday, moving down 1.74%.
  • Nikola (NASDAQ:NKLA) stock dropped to a yearly low on Monday of $12.02. Shares traded down 3.36%.
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) shares reached a new 52-week low of $20.13 on Monday morning, moving up 0.12%.
  • Reata Pharmaceuticals (NASDAQ:RETA) shares moved down 2.02% on Monday to hit a new 52-week low of $86.00, drifting down 2.02%.
  • Telecom Argentina (NYSE:TEO) stock hit $5.20 on Monday morning, setting a new 52-week low for a change of up 0.38%.
  • Axsome Therapeutics (NASDAQ:AXSM) stock achieved a new 52-week low on Monday morning, hitting $51.55 and moving down 2.02%.
  • Coherus BioSciences (NASDAQ:CHRS) shares fell to $13.69 on Monday, setting a new 52-week low with a shift of down 1.58%.
  • Adverum Biotechnologies (NASDAQ:ADVM) stock set a new 52-week low of $8.90 on Monday, moving down 1.43%.
  • Vasta Platform (NASDAQ:VSTA) shares made a new 52-week low of $8.73 on Monday. The stock was down 4.03% for the day.
  • BEST (NYSE:BEST) stock hit a new 52-week low of $1.55. The stock was down 0.75% on the session.
  • Sigilon Therapeutics (NASDAQ:SGTX) shares hit a yearly low of $16.74. The stock was up 0.23% on the session.
  • Atreca (NASDAQ:BCEL) shares moved down 2.6% on Monday to hit a new 52-week low of $11.88, drifting down 2.6%.
  • Syros Pharmaceuticals (NASDAQ:SYRS) stock achieved a new 52-week low on Monday morning, hitting $6.32 and moving down 2.14%.
  • Puxin (NYSE:NEW) shares reached a new 52-week low of $3.38 on Monday morning, moving down 3.72%.
  • Puyi (NASDAQ:PUYI) shares moved down 1.93% on Monday to hit a new 52-week low of $4.05, drifting down 1.93%.
  • Lannett (NYSE:LCI) stock hit a new 52-week low of $4.77. The stock was down 2.52% on the session.
  • Assembly Biosciences (NASDAQ:ASMB) shares were down 2.06% for the day, having made a 52-week low of $4.20.
  • Calithera Biosciences (NASDAQ:CALA) stock drifted down 3.06% on Monday morning to hit a new 52-week low of $2.23.
  • ContraFect (NASDAQ:CFRX) stock drifted down 1.43% on Monday morning to hit a new 52-week low of $4.04.
  • NeuBase Therapeutics (NASDAQ:NBSE) shares hit a yearly low of $6.17. The stock was down 0.92% on the session.
  • Concert Pharmaceuticals (NASDAQ:CNCE) stock achieved a new 52-week low on Monday morning, hitting $4.45 and moving down 1.75%.
  • CooTek (Cayman) (NYSE:CTK) shares moved down 7.48% on Monday to hit a new 52-week low of $2.31, drifting down 7.48%.
  • TD Hldgs (NASDAQ:GLG) shares were down 11.88% for the day, having made a 52-week low of $1.34.
  • Metacrine (NASDAQ:MTCR) shares fell to $5.10 on Monday, setting a new 52-week low with a shift of down 0.39%.
  • Imara (NASDAQ:IMRA) stock hit a new 52-week low of $7.43. The stock was down 1.5% on the session.
  • Qualigen Therapeutics (NASDAQ:QLGN) stock drifted down 14.23% on Monday morning to hit a new 52-week low of $2.15.
  • Idera Pharmaceuticals (NASDAQ:IDRA) stock dropped to a yearly low on Monday of $1.21. Shares traded down 3.57%.
  • Astrotech (NASDAQ:ASTC) shares moved down 6.12% on Monday to hit a new 52-week low of $1.35, drifting down 6.12%.
  • Millendo Therapeutics (NASDAQ:MLND) stock dropped to a yearly low on Monday of $1.12. Shares traded down 0.86%.

 

Benzinga will update traders on these companies going forward. If these companies break to a new level, Benzinga will be the first to report on it.

Read the original

Advertisement